Eton Pharmaceuticals (ETON) Revenue (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Revenue of $21.3 million for Q4 2025, down 5.25% sequentially from $22.5 million in Q3 2025, and up 82.72% YoY from $11.6 million in Q4 2024.
Eton Pharmaceuticals (ETON) Revenue (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Revenue for 7 years, with the latest figure at $21.3 million in Q4 2025.
- Quarterly Revenue rose 82.72% year-over-year to $21.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $80.0 million (up 104.94% YoY) and the FY2025 annual result came in at $80.0 million, up 104.94% from the prior year.
- Revenue declined to $21.3 million in Q4 2025 per ETON's latest filing, from $22.5 million in the prior quarter.
- Over five years, Revenue peaked at $29.8 million in Q4 2023 and troughed at $775000.0 in Q3 2021.
- A 5-year average of $10.8 million and a median of $8.8 million in 2022 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2022: Revenue soared 203200.0% in 2021, then sank 81.71% in 2022.
- Over 5 years, Revenue stood at $6.1 million in 2021, then soared by 39.47% to $8.5 million in 2022, then surged by 250.69% to $29.8 million in 2023, then slumped by 60.92% to $11.6 million in 2024, then jumped by 82.72% to $21.3 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $21.3 million, $22.5 million, and $18.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.71 Bn | 1.68 Bn | 25.41 Mn | 37.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.59 Mn |
| Dec 31, 2025 | 21.28 Mn |
| Sep 30, 2025 | 22.46 Mn |
| Jun 30, 2025 | 18.93 Mn |
| Mar 31, 2025 | 17.28 Mn |
| Dec 31, 2024 | 11.65 Mn |
| Sep 30, 2024 | 10.32 Mn |
| Jun 30, 2024 | 9.07 Mn |
| Mar 31, 2024 | 7.97 Mn |
| Dec 31, 2023 | 29.80 Mn |
| Sep 30, 2023 | 7.03 Mn |
| Jun 30, 2023 | 12.00 Mn |
| Mar 31, 2023 | 5.30 Mn |
| Dec 31, 2022 | 8.50 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 2.18 Mn |
| Dec 31, 2021 | 6.09 Mn |
| Sep 30, 2021 | 775,000.00 |
| Jun 30, 2021 | 3.07 Mn |